Stockscreener 앱 받기
6.63
27.26%
1.42
시간 외 거래:
6.80
0.17
+2.56%
전일 마감가:
$5.21
열려 있는:
$5.01
하루 거래량:
7.76M
Relative Volume:
2.85
시가총액:
$16.88M
수익:
-
순이익/손실:
$-7.97M
주가수익비율:
-1.7034
EPS:
-3.8923
순현금흐름:
$-6.79M
1주 성능:
+32.34%
1개월 성능:
+258.38%
6개월 성능:
+61.71%
1년 성능:
-20.79%
1일 변동 폭
$5.0053
$7.5392
1주일 범위
$3.37
$7.5392
52주 변동 폭
$1.3259
$21.00
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
명칭
Acurx Pharmaceuticals Inc
전화
917-533-1469
주소
259 LIBERTY AVENUE, STATEN ISLAND
Compare ACXP vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
6.63 | 13.27M | 0 | -7.97M | -6.79M | -3.8923 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Acurx Pharmaceuticals Inc 주식(ACXP)의 최신 뉴스
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Can Acurx Pharmaceuticals (ACXP) Surge by 226.3% to Meet the Target Set by Wall Street Analysts? - Bitget
Can Acurx Pharmaceuticals (ACXP) Rise by 226.3% to Meet the Target Set by Wall Street Experts? - Bitget
Can Acurx Pharmaceuticals (ACXP) Climb 226.3% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance
Acurx signals launch of pivotal recurrent CDI trial in H2 2026 while strengthening ibezapolstat pipeline - MSN
Why is Acurx Pharmaceuticals stock falling Thursday? - MSN
What's going on with Acurx Pharmaceuticals stock today? - MSN
Is Acurx Pharmaceuticals (ACXP) outperforming other medical stocks this year? - MSN
Acurx Pharmaceuticals Drives Stock Surge with Major Clinical Developments - StocksToTrade
Is Acurx Pharmaceuticals (ACXP) Surpassing Other Healthcare Stocks in Performance This Year? - Bitget
Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year? - Yahoo Finance
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Acurx Pharmaceuticals (ACXP) - The Globe and Mail
What's Going On With Acurx Pharmaceuticals Stock Today? - Sahm
Acurx Pharmaceuticals (ACXP) Gets a Buy from Alliance Global Partners - The Globe and Mail
Analysts Are Bullish on Top Healthcare Stocks: Acurx Pharmaceuticals (ACXP), BioLife Solutions (BLFS) - The Globe and Mail
Acurx Pharmaceuticals (ACXP) Stock Rockets 218% as Phase 3 CDI Trial Gets Green Light - MEXC
Acurx Pharmaceuticals, Inc. (ACXP) Stock: Reduces Net Loss While Expanding Ibezapolstat Clinical Program - parameter.io
Acurx Pharmaceuticals Reports Full Year and Q4 Results, Provides Business Update - National Today
Acurx Pharmaceuticals (ACXP) Stock Explodes 218% on CDI Clinical Trial Breakthrough - MEXC
Acurx Pharma Stock Dips 9% Amid Market Volatility - timothysykes.com
Acurx Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
ACXP: Strong phase II results and new rCDI trial drive momentum amid improved financials - TradingView
Earnings call transcript: Acurx Pharmaceuticals Q4 2025 reveals cash boost and R&D progress - Investing.com
ACXP: Ibezapolstat progresses toward first-in-class status for rCDI, with strong results and new trials - TradingView
Acurx Pharmaceuticals (ACXP) Stock Soars 218% Following Phase 3 CDI Trial Approval - parameter.io
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Times Record News
Acurx Pharmaceuticals stock gains over 3% on new rCDI trial launch - Investing.com Canada
Earnings Scheduled For March 13, 2026 - Benzinga
ACXP: Cash up, losses down, and ibezapolstat advances toward pivotal Phase 3 trials - TradingView
Acurx starts recurrent C. diff trial to treat and prevent - Stock Titan
Why Petco Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Sahm
Why Is Acurx Pharmaceuticals Stock Falling Thursday? - Sahm
Pullback Watch: What are the risks of holding Acurx Pharmaceuticals Inc2026 Movers & Weekly Top Gainers Trade List - baoquankhu1.vn
Acurx Pharmaceuticals Stock (ACXP) Explodes 218% as New Trial Moves Forward on 96% Cure Rate - TipRanks
Acurx Pharmaceuticals 10-K: $0 Revenue, Net Loss $7.97M - TradingView
Acurx Pharmaceuticals (ACXP) highlights ibezapolstat CDI data and $1B market - Stock Titan
Acurx Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
ACXP Should I Buy - Intellectia AI
Why is Acurx Pharmaceuticals stock up over 105% today? - MSN
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Best Pharmaceutical Stocks To Follow NowMarch 11th - MarketBeat
Why Is Acurx Pharmaceuticals Stock Up Over 105% Today? - Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Acurx Launches New Trial Amidst Promising Developments in C. Difficile Treatment - StocksToTrade
Acurx Pharma shares rise by 29% on new trial for breakthrough antibiotic ‘ibezapolstat’ - Mugglehead Magazine
Acurx Launches Revolutionary Trials for C. difficile Drug - timothysykes.com
Acurx Pharmaceuticals Inc expected to post a loss of $1.01 a shareEarnings Preview - TradingView
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Acurx Pharmaceuticals Inc (ACXP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):